Hemagen Diagnostics (Hemagen Diagnostics) Days Sales Outstanding : 61.09 (As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Days Sales Outstanding?

Hemagen Diagnostics's average Accounts Receivable for the three months ended in Sep. 2012 was $0.59 Mil. Hemagen Diagnostics's Revenue for the three months ended in Sep. 2012 was $0.88 Mil. Hence, Hemagen Diagnostics's Days Sales Outstanding for the three months ended in Sep. 2012 was 61.09.

The historical rank and industry rank for Hemagen Diagnostics's Days Sales Outstanding or its related term are showing as below:

HMGN's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.34
* Ranked among companies with meaningful Days Sales Outstanding only.

Hemagen Diagnostics's Days Sales Outstanding increased from Sep. 2011 (48.41) to Sep. 2012 (61.09).

Hemagen Diagnostics Days Sales Outstanding Historical Data

The historical data trend for Hemagen Diagnostics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Days Sales Outstanding Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Days Sales Outstanding

Get a 7-Day Free Trial

53.45

50.38

45.45

44.37

52.74

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Days Sales Outstanding	Get a 7-Day Free Trial															48.41	41.17	41.44	56.55	61.09

Competitive Comparison of Hemagen Diagnostics's Days Sales Outstanding

For the Biotechnology subindustry, Hemagen Diagnostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemagen Diagnostics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Days Sales Outstanding falls into.

Hemagen Diagnostics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hemagen Diagnostics's Days Sales Outstanding for the fiscal year that ended in Sep. 2012 is calculated as

	Days Sales Outstanding (A: Sep. 2012 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2011 )	+	Accounts Receivable (A: Sep. 2012 ))	/	count )	/	Revenue (A: Sep. 2012 )	*	Days in Period
=	( (0.58	+	0.588)	/	2 )	/	4.042	*	365
=	0.584					/	4.042	*	365
=	52.74

Hemagen Diagnostics's Days Sales Outstanding for the quarter that ended in Sep. 2012 is calculated as:

	Days Sales Outstanding (Q: Sep. 2012 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2012 )	+	Accounts Receivable (A: Sep. 2012 ))	/	count )	/	Revenue (A: Sep. 2012 )	*	Days in Period
=	( (0.585	+	0.588)	/	2 )	/	0.876	*	365 / 4
=	0.5865					/	0.876	*	365 / 4
=	61.09

Hemagen Diagnostics (OTCPK:HMGN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hemagen Diagnostics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines